Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-05-19
1998-01-20
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 64, A61K 3170
Patent
active
057101345
ABSTRACT:
The invention relates to a combination of substances (component I) inducing necrosis in tumors or inflamed tissue with other nontoxic substances ("prodrugs", component II). The enzymes set free by necrotic processes then cleave the nontoxic "prodrug" into the toxic "drug", which leads to massive tumor cell death and/or remission of inflammation.
REFERENCES:
patent: 3590028 (1971-06-01), Arcamone et al.
patent: 4012448 (1977-03-01), Smith et al.
patent: 4874780 (1989-10-01), Borretzen et al.
patent: 5219739 (1993-06-01), Tischer et al.
Senter et al., "Generation of Cytotoxic Agents By Targeted Enzymes", Bioconjugate Chem., vol. 4:3-9, (1993).
Terman et al., "Identification of a New Endothelial Cell Growth Factor Receptor Tyrosine Kinase", Oncogene, vol. 6:1677-1683, (1991).
Ullrich et al., "Signal Tansduction by Receptors With Tyrosine Kinase Activity", Cell, vol. 61:203-212, (1990).
Millauer et al., "High Affinity VEGF Binding and Developmental Expression Suggest Flk-1 As A Major Regulator of Vasculogenesis and Angiogenesis", Cell, vol. 72:835-846, (1993).
Millauer et al., "Glioblastoma Growth Inhibited in vivo By A Dominant-Negative Flk-1 Mutant", Nature, vol. 367:576-579, (1994).
Kaipainen et al., "The Related FLT4, FLT1, and KDR Receptor Tyrosine Dinases Show Distinct Expression Patterns in Human Fetal Endothelial Cells", J. Exp. Med., vol. 178:2077-2088, (1993).
Plate et al., "Up-Regulation Of Vascular Endothelial Growth Factor And Its Cognate Receptors In A Rat Glioma Model Of Tumor Angiogenesis", Cancer Research, vol. 53:5822-5827, (1993).
Clarke et al., "The Identification Of Proliferation And Tumour-Induced Proteins In Human Endothelial Cells: A Possible Target For Tumour Therapy", Electrophoresis, vol. 12:500-508, (1991).
Hagemeier et al., "A Monoclonal Antibody Reacting With Endothelial Cells Of Budding Vessels In Tumors And Inflammatory Tissues, And Non-Reactive With Normal Adult Tissues", Int. J. Cancer,vol. 38:481-488, (1986).
Brooks et al., "Requirement of Vascular Integrin .alpha..sub.v .beta..sub.3 For Angiogenesis", Science, vol. 264:569-571, (1994).
Brooks et al., "Integrin .alpha..sub.v .beta..sub.3 Antagonists Promote Tumor Regression By Inducing Apoptosis Of Angiogenic Blood Vessels", Cell, vol. 79:1157-1164, (1994).
Terman et al., "Identifiacation Of The KDR Tyrosine Kinase As A Receptor For Vascular Endothelial Cell Growth Factor", Biochemical And Biophysical Research Communications, vol. 187, No. 3, pp. 1579-1586, (1992).
Carnemolla et al., "A Tumor-Associated Fibronectin Isoform Generated By Alternative Splicing OF Messenger RNA Precursors", The Journal of Cell Biology, vol. 108:1139-1148, (1989).
Castellani et al., "The Fibronectin Isoform Containing The ED-B Oncofetal Domain: A Marker Of Angiogenesis", Int. J. Cancer, vol. 59:612-618, (1994).
Fernandez-Ruiz et al., "Assignment of The Human Endoglin Gene (END) to 9q34.fwdarw.qter", Cytogenet Cell Genet, vol. 64:204-207, (1993).
Gougos et al., "Primary Structure Of Endoglin, An RGD-Containing Glycoprotein Of Human Endothelial Cells", The Journal of Biological Chemistry, vol. 265, No. 15, pp. 8361-8364, (1990).
Wang et al., "A Monoclonal Antibody Detects Heterogeneity In Vascular Endothelium Of Tumours And Normal Tissues", Int. J. Cancer, vol. 54:363-370, (1993).
Wang et al., "Quantitation Of Endothelial Cell Specific Protein E-9 Employing A Single Monoclonal Antibody In An Indirect Sandwich ELISA", Journal of Immunological Methods, vol. 171:55-64, (1994).
Westphal et al., "A New 180-kDa Dermal Endothelial Cell Activation Antigen: In Vitro and In Situ Characteristics", The Journal of Investigative Dermatology, vol. 100, No. 1, pp. 27-34, (1993).
Shibuya et al., "Nucleotide Sequence And Expression Of A Novel Human Receptor-Type Tyrosine Kinase Gene (flt) Closely Realted To The fms Family", Oncogene, vol. 5:519-524, (1990).
Bosslet Klaus
Czech Jorg
Hoffmann Dieter
Behringwerke Aktiengesellschaft
Reamer James H.
LandOfFree
Combination of necrosis-inducing substances with substances whic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of necrosis-inducing substances with substances whic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of necrosis-inducing substances with substances whic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-725409